SCHEMBL31661723

SCHEMBL31661723

O=C(O)CCCCCCCNC(=O)c1coc2ccccc2c1=O

nearest known ligand 0.67

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ MAOB P27338 11/20 0.67
▸ GAA P10253 1/20 0.60
▸ TNF P01375 1/20 0.58
▸ ADORA2B P29275 2/20 0.57
▸ CA12 O43570 2/20 0.55
▸ CA1 P00915 2/20 0.55
▸ CA2 P00918 2/20 0.55
▸ CA4 P22748 2/20 0.55
▸ CA5A P35218 2/20 0.55
▸ CA7 P43166 2/20 0.55
▸ CA5B Q9Y2D0 2/20 0.55
▸ KMT2A Q03164 2/20 0.55
▸ MEN1 O00255 1/20 0.53
▸ DRD2 P14416 1/20 0.53
▸ DRD3 P35462 1/20 0.53
▸ L3MBTL1 Q9Y468 1/20 0.53
▸ MAOA P21397 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5655981 1.00 MAOB (0.67) MAOBGAATNFADORA2BCA12
SCHEMBL5656236 0.77 MAOB (0.70) MAOBADORA2BCA12CA1CA2
SCHEMBL31661715 0.77 MAOB (0.70) MAOBADORA2BCA12CA1CA2
SCHEMBL4236658 0.75 ACSL1 (0.60) MAOA
SCHEMBL1787628 0.75 ACSL1 (0.60) MAOA
SCHEMBL10244630 0.74 MAOB (0.69) MAOBGAATNFCA12CA1
SCHEMBL9829444 0.74 PPARG (0.74) —
SCHEMBL4973439 0.73 MAOB (1.00) MAOBADORA2BMAOA
SCHEMBL5655976 0.73 NPC1 (0.68) MAOBKMT2AMEN1L3MBTL1MAOA
SCHEMBL31661779 0.73 NPC1 (0.68) MAOBKMT2AMEN1L3MBTL1MAOA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025151884-A1 USE OF GLYCOSAMINOGLYCAN SULFATED POLYSACCHARIDES SUCH AS SODIUM PENTOSAN POLYSULFATE IN COMBINATION WITH PERMEATION AGENTS TO TREAT ALZHEIMER'S DISEASE PARSONS C LOWELL (US) 2025-07-17 — — WO claimed
WO-2025151884-A1 USE OF GLYCOSAMINOGLYCAN SULFATED POLYSACCHARIDES SUCH AS SODIUM PENTOSAN POLYSULFATE IN COMBINATION WITH PERMEATION AGENTS TO TREAT ALZHEIMER'S DISEASE PARSONS C LOWELL (US) 2025-07-17 — — WO disclosed
Send feedback